Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
Identifieur interne : 000297 ( PubMed/Checkpoint ); précédent : 000296; suivant : 000298Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
Auteurs : A Jon Stoessl [Canada]Source :
- Neurology [ 1526-632X ] ; 2016.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Dopamine Agents, Levodopa.
- diagnostic imaging : Dyskinesia, Drug-Induced, Globus Pallidus, Parkinson Disease.
- chemical , metabolism : Receptors, Dopamine D3.
- methods : Positron-Emission Tomography.
- Female, Humans, Male.
DOI: 10.1212/WNL.0000000000002297
PubMed: 26718570
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26718570Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name><affiliation wicri:level="1"><nlm:affiliation>From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health</wicri:regionArea><wicri:noRegion>University of British Columbia & Vancouver Coastal Health</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26718570</idno><idno type="pmid">26718570</idno><idno type="doi">10.1212/WNL.0000000000002297</idno><idno type="wicri:Area/PubMed/Corpus">000306</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000306</idno><idno type="wicri:Area/PubMed/Curation">000306</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000306</idno><idno type="wicri:Area/PubMed/Checkpoint">000306</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000306</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name><affiliation wicri:level="1"><nlm:affiliation>From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health</wicri:regionArea><wicri:noRegion>University of British Columbia & Vancouver Coastal Health</wicri:noRegion></affiliation></author></analytic><series><title level="j">Neurology</title><idno type="eISSN">1526-632X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine Agents (adverse effects)</term><term>Dyskinesia, Drug-Induced (diagnostic imaging)</term><term>Female</term><term>Globus Pallidus (diagnostic imaging)</term><term>Humans</term><term>Levodopa (adverse effects)</term><term>Male</term><term>Parkinson Disease (diagnostic imaging)</term><term>Positron-Emission Tomography (methods)</term><term>Receptors, Dopamine D3 (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Dyskinesia, Drug-Induced</term><term>Globus Pallidus</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptors, Dopamine D3</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Positron-Emission Tomography</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26718570</PMID><DateCreated><Year>2016</Year><Month>01</Month><Day>19</Day></DateCreated><DateCompleted><Year>2016</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?</ArticleTitle><Pagination><MedlinePgn>228</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000002297</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stoessl</LastName><ForeName>A Jon</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050637">Receptors, Dopamine D3</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Neurology. 2016 Jan 19;86(3):224-30</RefSource><PMID Version="1">26718579</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004409" MajorTopicYN="N">Dyskinesia, Drug-Induced</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005917" MajorTopicYN="N">Globus Pallidus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050637" MajorTopicYN="N">Receptors, Dopamine D3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26718570</ArticleId><ArticleId IdType="pii">WNL.0000000000002297</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000002297</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000297 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000297 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26718570
|texte= Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26718570" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |